GLOBRYTE: A Phase III, Open-Label, Multicenter, Randomized Trial Evaluating Glofitamab Monotherapy in Patients with Relapsed or Refractory Mantle Cell Lymphoma
Clinical Lymphoma Myeloma and Leukemia（2024）
关键词
MCL,clinical trials,non-Hodgkin lymphoma,bispecific antibody therapy,adverse events,mantle cell lymphoma,phase 3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要